Victory Capital Management Inc. Sells 7,474 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Victory Capital Management Inc. decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 5.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135,003 shares of the company’s stock after selling 7,474 shares during the period. Victory Capital Management Inc.’s holdings in HCA Healthcare were worth $54,869,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the stock. OVERSEA CHINESE BANKING Corp Ltd grew its stake in shares of HCA Healthcare by 23.2% in the third quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 2,923 shares of the company’s stock valued at $1,188,000 after buying an additional 550 shares in the last quarter. GSA Capital Partners LLP acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $567,000. Waverton Investment Management Ltd raised its stake in HCA Healthcare by 12.7% in the 3rd quarter. Waverton Investment Management Ltd now owns 159,382 shares of the company’s stock valued at $64,767,000 after acquiring an additional 17,968 shares during the period. Nations Financial Group Inc. IA ADV acquired a new position in shares of HCA Healthcare in the third quarter valued at $325,000. Finally, Venturi Wealth Management LLC increased its stake in shares of HCA Healthcare by 13.4% during the third quarter. Venturi Wealth Management LLC now owns 5,335 shares of the company’s stock worth $2,168,000 after purchasing an additional 629 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HCA has been the topic of several research reports. Leerink Partners upped their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. KeyCorp dropped their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Morgan Stanley initiated coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. Barclays decreased their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. Finally, Wells Fargo & Company raised their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday, November 6th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,155 shares of company stock valued at $5,608,990 over the last ninety days. 1.60% of the stock is owned by company insiders.

HCA Healthcare Trading Down 1.1 %

HCA opened at $345.36 on Friday. The firm has a market capitalization of $87.48 billion, a price-to-earnings ratio of 15.51, a PEG ratio of 1.35 and a beta of 1.68. The company’s 50 day moving average price is $387.05 and its two-hundred day moving average price is $357.11. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a fifty-two week low of $237.57 and a fifty-two week high of $417.14.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.76%. HCA Healthcare’s payout ratio is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.